Inventor · disambiguated record
Jerome Deval
Also filed as: DEVAL JEROME
28 granted patents·15 pending applications·530 citations·filing 2010–2024
96Inventor score
Files withALIGOS THERAPEUTICS INC17ALIOS BIOPHARMA INC15JANSSEN BIOPHARMA INC6BEIGELMAN LEONID2BLUEJAY THERAPEUTICS INC1
Top patents by PatentIndex Score
43 records- 0198US9073960B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2012·Granted Jul 7, 2015·33 cites·40 claims
- 0298US8772474B2Cyclic nucleotide analogsBEIGELMAN LEONID·Filed 2011·Granted Jul 8, 2014·76 cites·43 claims
- 0397US11091467B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·6 cites·17 claims
- 0497US9278990B2Substituted nucleotide analogsALIOS BIOPHARMA INC·Filed 2014·Granted Mar 8, 2016·60 cites·31 claims
- 0596US8877731B2Azido nucleosides and nucleotide analogsBEIGELMAN LEONID·Filed 2011·Granted Nov 4, 2014·70 cites·30 claims
- 0696US8871737B2Substituted nucleotide analogsSMITH DAVID BERNARD·Filed 2011·Granted Oct 28, 2014·131 cites·65 claims
- 0795US10464965B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2015·Granted Nov 5, 2019·10 cites·27 claims
- 0895US9346848B2Azido nucleosides and nucleotide analogsALIOS BIOPHARMA INC·Filed 2014·Granted May 24, 2016·17 cites·18 claims
- 0994US9365605B2Cyclic nucleotide analogsALIOS BIOPHARMA INC·Filed 2014·Granted Jun 14, 2016·19 cites·24 claims
- 1093US10370401B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2017·Granted Aug 6, 2019·17 cites·41 claims
- 1193US9862743B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2014·Granted Jan 9, 2018·21 cites·6 claims
- 1292US12018015B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·2 cites·21 claims
- 1392US9815864B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2014·Granted Nov 14, 2017·38 cites·17 claims
- 1490US11760761B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·26 claims
- 1590US10485815B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2016·Granted Nov 26, 2019·5 cites·25 claims
- 1689US11760764B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·24 claims
- 1788US9441007B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2013·Granted Sep 13, 2016·11 cites·55 claims
- 1884US11149049B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2018·Granted Oct 19, 2021·2 cites·20 claims
- 1984US11021509B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2019·Granted Jun 1, 2021·1 cites·25 claims
- 2083US2025304561A1Modulators of thr-beta and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2181US11198699B2Compounds targeting PRMT5ALIGOS THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·1 cites·26 claims
- 2279US10364226B2Pyridazinone compounds and uses thereofALIOS BIOPHARMA INC·Filed 2014·Granted Jul 30, 2019·3 cites·36 claims
- 2376USRE48171ESubstituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2013·Granted Aug 25, 2020·3 cites·57 claims
- 2473US11773126B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Oct 3, 2023·0 cites·8 claims
- 2573US2021179656A1Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2671US12180192B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·23 claims
- 2767US2025026745A117-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereofBLUEJAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2866US2024352464A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2965US2022048922A1Compounds targeting prmt5ALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3060US11858913B2Bicyclic pyridazinones and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·18 claims
- 3159US11840532B2Modulators of THR-β and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·12 claims
- 3259US11793815B2Oxindoles and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·0 cites·23 claims
- 3359US11786532B22-pyridones and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·19 claims
- 3457US2025243491A1Pnpla3-targeting short interfering rna (sirna) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3556US2016264610A1Azido nucleosides and nucleotide analogsALIOS BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 3655US2025011789A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3755US2024368128A1Pyridazinone and methods of use thereofALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3852US2022112194A1Compounds targeting prmt5ALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3951US2017002037A1Cyclic nucleotide analogsALIOS BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4047US2019381081A1Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4146US2018079774A1Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4240US2019169221A1Substituted nucleosides, nucleotides and analogs thereofJANSSEN BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4337US2010331397A12-5a analogs and their methods of useALIOS BIOPHARMA INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerome Deval files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →